U.S. markets open in 2 hours 57 minutes
  • S&P Futures

    4,059.75
    -15.75 (-0.39%)
     
  • Dow Futures

    34,337.00
    -122.00 (-0.35%)
     
  • Nasdaq Futures

    11,982.25
    -28.00 (-0.23%)
     
  • Russell 2000 Futures

    1,887.50
    -6.90 (-0.36%)
     
  • Crude Oil

    81.91
    +1.93 (+2.41%)
     
  • Gold

    1,809.20
    -0.40 (-0.02%)
     
  • Silver

    23.26
    +0.01 (+0.04%)
     
  • EUR/USD

    1.0557
    +0.0027 (+0.25%)
     
  • 10-Yr Bond

    3.5060
    0.0000 (0.00%)
     
  • Vix

    20.06
    +0.22 (+1.11%)
     
  • GBP/USD

    1.2267
    -0.0029 (-0.24%)
     
  • USD/JPY

    135.3490
    +1.0780 (+0.80%)
     
  • BTC-USD

    17,306.57
    +331.93 (+1.96%)
     
  • CMC Crypto 200

    410.38
    +8.95 (+2.23%)
     
  • FTSE 100

    7,577.63
    +21.40 (+0.28%)
     
  • Nikkei 225

    27,820.40
    +42.50 (+0.15%)
     

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation (NYSE:CNMD) has announced that it will pay a dividend of $0.20 per share on the 5th of October. Including this payment, the dividend yield on the stock will be 0.8%, which is a modest boost for shareholders' returns.

See our latest analysis for CONMED

CONMED's Earnings Easily Cover The Distributions

While yield is important, another factor to consider about a company's dividend is whether the current payout levels are feasible. Even though CONMED isn't generating a profit, it is generating healthy free cash flows that easily cover the dividend. We generally think that cash flow is more important than accounting measures of profit, so we are fairly comfortable with the dividend at this level.

Looking forward, earnings per share is forecast to rise exponentially over the next year. If the dividend extends its recent trend, estimates say the dividend could reach 5.1%, which we would be comfortable to see continuing.

historic-dividend
historic-dividend

CONMED Has A Solid Track Record

The company has a sustained record of paying dividends with very little fluctuation. The annual payment during the last 10 years was $0.60 in 2012, and the most recent fiscal year payment was $0.80. This works out to be a compound annual growth rate (CAGR) of approximately 2.9% a year over that time. Dividends have grown relatively slowly, which is not great, but some investors may value the relative consistency of the dividend.

Dividend Growth Potential Is Shaky

Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. However, initial appearances might be deceiving. Earnings per share has been sinking by 19% over the last five years. Such rapid declines definitely have the potential to constrain dividend payments if the trend continues into the future. On the bright side, earnings are predicted to gain some ground over the next year, but until this turns into a pattern we wouldn't be feeling too comfortable.

Our Thoughts On CONMED's Dividend

Overall, it's nice to see a consistent dividend payment, but we think that longer term, the current level of payment might be unsustainable. The company has been bring in plenty of cash to cover the dividend, but we don't necessarily think that makes it a great dividend stock. We would probably look elsewhere for an income investment.

It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. However, there are other things to consider for investors when analysing stock performance. Just as an example, we've come across 2 warning signs for CONMED you should be aware of, and 1 of them is a bit unpleasant. Is CONMED not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here